Facts of Trulicity (dulaglutide)
TRULICITY (dulaglutide) injection, for subcutaneous use
Initial U.S. Approval: 2014
Generic Name: dulaglutide
Company: Eli Lilly
Mechanism of Action: Glucagon-like peptide 1 (GLP-1) receptor agonist
South Delhi Pharma can facilitate patients and physicians access to commercially approved medicines, “Trulicity (dulaglutide) ” to all locations in the world and in India after fulfilling the legal requirement (if applicable). Trulicity (dulaglutide) is a prescription drug and should be used under proper medical guidance and advice. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.
Get In Touch
Get in touch with us at South Delhi Pharma (SDP), and one of our team will be on hand to help with any queries you may have.
The SDM is open
Monday to Friday.
Business hours: 09:30 A.M to 18:30 P.M.
M:+91-9891296838 / P:+91-11- 26532129
What Trulicity is?
TRULICITY® is a glucagon-like peptide-1 (GLP-1) receptor agonist indicated:
• as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
• to reduce the risk of major adverse cardiovascular events in adults with type 2 diabetes mellitus who have established cardiovascular disease or multiple cardiovascular risk factors
What Dulaglutide is?
Dulaglutide, sold under the brand name Trulicity among others, is a medication used for the treatment of type 2 diabetes in combination with diet and exercise. It is also approved in the United States for the reduction of major adverse cardiovascular events in adults with type 2 diabetes who have established cardiovascular disease or multiple cardiovascular risk factors.